HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thromboxane synthase expression and thromboxane A2 production in the atherosclerotic lesion.

Abstract
Thromboxane A(2) (TXA(2)) is a potent prothrombotic and immune modulating lipid mediator, which is implicated in cardiovascular diseases, in particular, atherosclerotic lesion development and thrombogenicity. Here, we tested the hypothesis that thromboxane synthase (TXAS), the obligate enzyme required to synthesize TXA(2), is expressed within the human atherosclerotic lesion, thus potentially contributing to TXA(2) synthesis and disease development. In an animal study, different atherosclerosis-prone mouse strains were investigated and compared with control mice. In a patient study (n = 134), endarterectomies of carotid atherosclerotic lesions were compared with non-atherosclerotic arteries (n = 11). Expression of TXAS was evaluated by real-time quantitative reverse transcription PCR and immunohistochemistry. TXAS mRNA expression was increased within the vascular wall in mouse models of atherosclerosis with advanced lesions. In humans, TXAS was expressed in the atherosclerotic lesion, associated with increased inflammatory cells, in particular M2 polarized macrophages, and increased in atherosclerotic lesions of patients with recent symptoms of thrombotic events. Production of TXA(2) by plaque tissue, verified by gas chromatography-mass spectrometry, increased after addition of arachidonic acid or lipopolysaccharide, and was inhibited by the TXAS inhibitor furegrelate. The findings suggest that intraplaque TXA(2) generation may contribute to the development of atherosclerosis and its thrombotic complications in humans.
AuthorsAnders Gabrielsen, Hong Qiu, Magnus Bäck, Mats Hamberg, Anne-Louise Hemdahl, Hanna Agardh, Lasse Folkersen, Jesper Swedenborg, Ulf Hedin, Gabrielle Paulsson-Berne, Jesper Z Haeggström, Göran K Hansson
JournalJournal of molecular medicine (Berlin, Germany) (J Mol Med (Berl)) Vol. 88 Issue 8 Pg. 795-806 (Aug 2010) ISSN: 1432-1440 [Electronic] Germany
PMID20383787 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • RNA, Messenger
  • Thromboxane A2
  • Thromboxane-A Synthase
Topics
  • Animals
  • Atherosclerosis (enzymology, pathology)
  • Female
  • Gene Expression
  • Humans
  • Mice
  • Mice, Inbred C57BL
  • RNA, Messenger (genetics)
  • Thromboxane A2 (metabolism)
  • Thromboxane-A Synthase (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: